*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Effect of Concentration of Plasma Homocysteine

Author: DR. JADHAV
Abstract: For new risk factors to be meaningful in disease prevention in any population, they must either be responsible for a substantial proportion of the disease burden, or their modification must have a tangible impact on disease prevalence in that population. The major known variable risk factors also describe at least 75% of new cases of cardiovascular disease in the Western world. Physicians and their patients must therefore not lose sight of the fact that lifestyle changes incorporating smoking cessation, a heart healthy diet, weight reduction and regular physical activity together with drug therapy for dyslipidaemia, still remain the cornerstones of CVD prevention in our population. The routine measurement of plasma homocysteine and the use of specific therapies directed at reducing elevated levels is not yet recommended.
Keyword: Coronary Artery Disease, Homocysteine, Atherosclerosis, Myocardial Infraction
DOI: https://doi.org/10.31838/ijpr/2020.12.03.225
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free